Vigil Neuroscience (VIGL) Short Interest Ratio & Short Volume → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free VIGL Stock Alerts $3.54 +0.06 (+1.72%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Vigil Neuroscience Short Interest DataCurrent Short Volume1,160,000 sharesPrevious Short Volume921,000 sharesChange Vs. Previous Month+25.95%Dollar Volume Sold Short$3.03 millionShort Interest Ratio / Days to Cover12.3Last Record DateApril 30, 2024Outstanding Shares37,580,000 sharesFloat Size25,170,000 sharesShort Percent of Float4.61%Today's Trading Volume32,182 sharesAverage Trading Volume104,341 sharesToday's Volume Vs. Average31% Short Selling Vigil Neuroscience ? Sign up to receive the latest short interest report for Vigil Neuroscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVIGL Short Interest Over TimeVIGL Days to Cover Over TimeVIGL Percentage of Float Shorted Over Time Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. Vigil Neuroscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,160,000 shares $3.03 million +26.0%4.6%12.3 $2.61 4/15/2024921,000 shares $2.91 million -6.8%6.2%10.5 $3.16 3/31/2024987,900 shares $3.37 million -5.0%7.1%10.9 $3.41 3/15/20241,040,000 shares $3.48 million +16.7%7.6%8.9 $3.35 2/29/2024891,100 shares $3.10 million +10.3%6.5%8.3 $3.48 2/15/2024807,800 shares $2.63 million +8.9%5.9%6.9 $3.25 Get the Latest News and Ratings for VIGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vigil Neuroscience and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024742,000 shares $2.02 million +9.3%5.7%5.5 $2.72 1/15/2024678,600 shares $2.23 million -9.2%5.2%5.2 $3.28 12/31/2023747,400 shares $2.53 million +19.0%5.8%5.9 $3.38 12/15/2023628,100 shares $2.26 million -8.9%4.8%6 $3.60 11/30/2023689,700 shares $2.19 million -14.9%5.3%7.4 $3.18 11/15/2023810,600 shares $5.40 million +5.1%6.3%10.2 $6.66 10/31/2023771,100 shares $5.40 million -8.0%6.1%17.4 $7.00 10/15/2023838,200 shares $4.90 million -3.5%6.6%19.3 $5.84 9/30/2023868,300 shares $4.68 million +7.3%6.8%17.6 $5.39 9/15/2023809,500 shares $5.50 million +3.0%6.4%16.3 $6.79 8/31/2023785,700 shares $4.74 million +8.8%5.4%9.7 $6.03 8/15/2023722,300 shares $4.22 million +31.7%4.9%8.8 $5.84 7/31/2023548,500 shares $4.46 million -24.0%3.8%6.9 $8.14 7/15/2023721,200 shares $6.74 million +4.5%5.0%9.5 $9.35 6/30/2023690,500 shares $6.49 million +45.2%4.8%9.9 $9.40 6/15/2023475,600 shares $4.76 million +0.1%3.3%7.1 $10.00 5/31/2023475,000 shares $4.75 million -14.6%3.3%16.4 $10.00 5/15/2023556,400 shares $4.80 million +4.4%3.9%22.8 $8.63 4/30/2023533,100 shares $4.64 million +5.7%3.7%23.9 $8.70 4/15/2023504,300 shares $4.80 million +9.5%3.5%25.1 $9.52 3/31/2023460,500 shares $4.51 million +2.8%3.2%22.8 $9.79 3/15/2023448,000 shares $3.98 million +4.8%3.9%20.3 $8.88 2/28/2023427,300 shares $5.13 million +0.5%3.7%14 $12.00 2/15/2023425,100 shares $4.89 million -1.1%3.0%13.1 $11.50 1/31/2023429,600 shares $4.66 million +7.0%3.3%12.2 $10.84 1/15/2023401,400 shares $4.80 million +1.6%3.1%10.9 $11.95 12/30/2022395,000 shares $4.94 million +29.5%3.0%10.4 $12.50 12/15/2022305,100 shares $3.82 million -0.2%2.3%8.7 $12.53 11/30/2022305,700 shares $3.82 million +8.2%2.3%12.5 $12.50 11/15/2022282,500 shares $3.11 million +1.2%2.2%13.3 $11.00 10/31/2022279,200 shares $4.38 million -4.7%2.7%16.8 $15.68 10/15/2022293,000 shares $4.68 million -1.7%2.8%17.3 $15.97 9/30/2022298,100 shares $2.71 million +0.2%N/A15.9 $9.10 9/15/2022297,600 shares $2.45 million -6.0%N/A7.1 $8.24POTUS in ‘25 Not Biden/Trump, But (Ad)And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. VIGL Short Interest - Frequently Asked Questions What is Vigil Neuroscience's current short interest? Short interest is the volume of Vigil Neuroscience shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,160,000 shares of VIGL short. 4.61% of Vigil Neuroscience's shares are currently sold short. Learn More on Vigil Neuroscience's current short interest. What is a good short interest ratio for Vigil Neuroscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VIGL shares currently have a short interest ratio of 12.0. Learn More on Vigil Neuroscience's short interest ratio. What is a good short interest percentage for Vigil Neuroscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.61% of Vigil Neuroscience's floating shares are currently sold short. Is Vigil Neuroscience's short interest increasing or decreasing? Vigil Neuroscience saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,160,000 shares, an increase of 26.0% from the previous total of 921,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vigil Neuroscience's float size? Vigil Neuroscience currently has issued a total of 37,580,000 shares. Some of Vigil Neuroscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vigil Neuroscience currently has a public float of 25,170,000 shares. How does Vigil Neuroscience's short interest compare to its competitors? 4.61% of Vigil Neuroscience's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Vigil Neuroscience: Scilex Holding (8.38%), Omega Therapeutics, Inc. (22.04%), Molecular Partners AG (0.15%), Cardiol Therapeutics Inc. (0.50%), aTyr Pharma, Inc. (0.92%), BioAtla, Inc. (11.08%), Vaxart, Inc. (10.44%), Sangamo Therapeutics, Inc. (6.92%), bluebird bio, Inc. (29.14%), Cardiff Oncology, Inc. (9.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Vigil Neuroscience stock? Short selling VIGL is an investing strategy that aims to generate trading profit from Vigil Neuroscience as its price is falling. VIGL shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vigil Neuroscience? A short squeeze for Vigil Neuroscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VIGL, which in turn drives the price of the stock up even further. How often is Vigil Neuroscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIGL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SCLX Short Interest OMGA Short Interest MOLN Short Interest CRDL Short Interest LIFE Short Interest BCAB Short Interest VXRT Short Interest SGMO Short Interest BLUE Short Interest CRDF Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VIGL) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe 1,000X Crypto PlaybookTrue Market InsidersCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMost important medical advance in 100 yearsThe Oxford ClubBill Clinton Backing Biden Replacement???The Freeport SocietyCharles Payne Demystifies OptionsUnstoppable ProsperityWhy Is Gold On a MASSIVE rally? Huge Alerts